Detalhe da pesquisa
1.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090602
2.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240755
3.
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1321-1337, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121900
4.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121899
5.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950880
6.
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Res Sq
; 2021 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580668
7.
Self-administration of vitamin D supplements in the general public may be associated with high 25-hydroxyvitamin D concentrations.
Ann Clin Biochem
; 54(3): 355-361, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422135
8.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413273
9.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968417
10.
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.
Lancet Haematol
; 8(6): e389-e392, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887255
11.
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
Bioorg Med Chem Lett
; 17(5): 1296-301, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17194588